Post by GSK on X
GSK@GSK
X#News for #investors and #media: Today we are announcing that our potential first-in-class treatment for chronic hepatitis B has been accepted for regulatory review in China.
Learn more: t.co
23 likes2 repliesPosted Mar 30, 2026